W
WAVEMAN · COMPANY
CNEY · Cn Energy Group. Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

CNEY

CN ENERGY GROUP. INC.
PHARMA & BIOTECH · INDUSTRIAL ORGANIC CHEMICALS · CIK 0001780785
SEC FILINGS☆ WATCH
INSIDER NET · 180D
-
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
3
13F, latest reported quarter
REVENUE GROWTH
-30.2%
XBRL, annual
NET MARGIN
-31.3%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
no Form 4 purchases or sales on file
CONGRESS
no member of Congress has reported trading it
FUNDS
3 funds added or opened last quarter
below 98% of Pharma & Biotech
REVENUE
-30.2% year over year
below 77% of Pharma & Biotech
MARGIN
-31.3% net margin
below 54% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
5.4% of shares outstanding short · 1.0 days to cover · settled 2026-07-31
more than 57% of Pharma & Biotech
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows 3 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for CN ENERGY GROUP. INC. in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE

no insider purchases or sales on record

0 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
XTX Topco Ltd
39,910.0 sh
$19.1K
UBS Group AG
12,253.0 sh
$5.9K
HRT FINANCIAL LP
17,974.0 sh
$8
SBI Securities Co., Ltd.
1.0 sh
$0
Caitong International Asset Management Co., Ltd
1.0 sh
$0
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-092024-092023-092022-09
REVENUE$35.6M$51.0M$57.9M$40.2M
GROSS PROFIT$647.6K$-181.1K$788.6K$3.6M
OPERATING INCOME$-11.0M$-12.5M$-6.2M$459.8K
NET INCOME$-11.1M$-14.0M$-5.6M$2.2M
EPS (DILUTED)-21.46-103.27-78.013.09
OPERATING CASH FLOW$-2.0M$-2.4M$-30.2M$-7.5M
LONG-TERM DEBT$0$34.3K$421.7K
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →